Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-385 in Uterine Fibroids
NCT01452659Phase 2Completed
- Sponsor
- Takeda
- Start
- Oct 2011
- Primary completion
- Sep 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of relugolix in Uterine Fibroids (UF), sponsored by Takeda. Started Oct 2011; status: completed.
02
Drugs
relugolix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT01452659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452659.